Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome
NCT06782243Completed
- Sponsor
- Khyber Medical University
- Start
- Dec 2024
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of atorvastatin and rosuvastatin in acute coronary syndrome (ACS) (2 arms), sponsored by Khyber Medical University. Primary endpoint: Reduction in Low-Density Lipoprotein Cholesterol Level at 3 months. Started Dec 2024; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06782243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06782243.